Thalidomide for refractory gastrointestinal bleeding from vascular malformations in patients with significant comorbidities

doi:10.12998/wjcc.v8.i15.3218

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 15

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8797)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

510

WORD

224

HTML

5596

Figures (1-2)

398

Tables (1-3)

488

Sum=7216

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

570

Download

1011

Sum=1581

Aug 6, 2020 (publication date) through Jan 8, 2025

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Aug 6, 2020; 8(15): 3218-3229
Published online Aug 6, 2020. doi: 10.12998/wjcc.v8.i15.3218

Full Size Figure Download Figure

Figure 1 Units of packed red blood cell transfused before and after initiation of thalidomide.

Citation: Bayudan AM, Chen CH. Thalidomide for refractory gastrointestinal bleeding from vascular malformations in patients with significant comorbidities. World J Clin Cases 2020; 8(15): 3218-3229
URL: https://www.wjgnet.com/2307-8960/full/v8/i15/3218.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i15.3218